https://www.yahoo.com/news/drug-restores-lost-alzheimer-memories-143056932.html
After two weeks of oral administration of the drug containing the molecule, the Alzheimer’s mice were able to recall maze escape routes at similar rates to their wild-type counterparts, and they also didn’t exhibit any weird behavior after being given the medicine.
As Mody notes, there’s an immense amount of work left to be done to determine whether DDL-920 could be safe and effective for humans. If the researchers get there, however, it could have huge implications for other disorders characterized by disruptions in gamma oscillation, which include autism spectrum disorder, depression, and schizophrenia.
“We are very enthusiastic about that,” Mody said in the press release, “because of the novelty and the mechanism of action that has not been tackled in the past.”